Intestinal Polyposis: Clinical Trials

6 trials for Intestinal Polyposis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 1 terminated. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Unknown 5, Terminated 1

Follow Intestinal Polyposis: new trials by email Literature Review of Intestinal Polyposis trials Research Report on Intestinal Polyposis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cold Snare Polypectomy for Small Bowel Polyps in Patients With Peutz-Jeghers Syndrome
Cold snare polypectomy - Peutz-Jeghers Syndrome, Small Bowel Polyp
Phase 4UnknownShandong University402023-08-202023-08-21
Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
Azithromycin Tablets - Familial Adenomatous Polyposis
Phase 4UnknownTel-Aviv Sourasky Medical Center102020-08-012020-07-01
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
Rapamycin - Peutz-Jeghers Syndrome
Phase 4UnknownPeking Union Medical College Hospital102018-09-162019-01-23
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version
Erythromycin - FAP-Familial Adenomatous Polyposis
Phase 4Unknownmichal roll152015-06-012015-02-03
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
Erythromycin - FAP-Familial Adenomatous Polyposis
Phase 4Unknownmichal roll202014-06-012014-06-26
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
MK0966; rofecoxib / Duration of Treatment: 24 weeks, Comparator: placebo / Duration of Treatment: 24 weeks - Adenomatous Polyposis Coli
Phase 4TerminatedMerck Sharp & Dohme LLC622002-08-062019-09-20

Narrower conditions

Adenomatous Polyposis Coli (4)  ·  Peutz-Jeghers Syndrome (2)  ·  Cancer Pain (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Osteoarthritis (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Digestive System Diseases (6)  ·  Gastrointestinal Diseases (6)  ·  Genetic Diseases, Inborn (6)  ·  Intestinal Diseases (6)  ·  Neoplasms (6)  ·  Neoplastic Syndromes, Hereditary (6)  ·  Adenoma (4)  ·  Adenomatous Polyps (4)  ·  Colonic Diseases (4)  ·  Colorectal Neoplasms (4)  ·  Digestive System Neoplasms (4)  ·  Gastrointestinal Neoplasms (4)  ·  Intestinal Neoplasms (4)

Interventions

Erythromycin (2)  ·  Azithromycin (1)  ·  Duration of Therapy (1)  ·  Sirolimus (1)  ·  rofecoxib (1)

Sponsors

michal roll (2)  ·  Merck Sharp & Dohme LLC (1)  ·  Peking Union Medical College Hospital (1)  ·  Shandong University (1)  ·  Tel-Aviv Sourasky Medical Center (1)

Countries

China (2)  ·  Israel (2)

Top investigators

Jiaolin Zhou, MD (1)  ·  Revital Kariv, MD (1)  ·  Revital Kariv, MD. (1)  ·  Rina Rosin-Arbeseld, Ph.D (1)  ·  Rina Rosin-Arbeseld, Ph.D. (1)

Results publications

PMID 20018966, PMID 42544942